B40
(2S)-N-methyl-1-phenylpropan-2-amine
Created: | 2009-03-19 |
Last modified: | 2021-03-01 |
Find Related PDB Entry |
---|
Find related ligands: |
---|
Chemical Details | |
---|---|
Formal Charge | 0 |
Atom Count | 26 |
Chiral Atom Count | 1 |
Bond Count | 26 |
Aromatic Bond Count | 6 |
Chemical Component Summary | |
---|---|
Name | (2S)-N-methyl-1-phenylpropan-2-amine |
Synonyms | Methamphetamine |
Systematic Name (OpenEye OEToolkits) | (2S)-N-methyl-1-phenyl-propan-2-amine |
Formula | C10 H15 N |
Molecular Weight | 149.233 |
Type | NON-POLYMER |
Chemical Descriptors | |||
---|---|---|---|
Type | Program | Version | Descriptor |
SMILES | ACDLabs | 10.04 | N(C(Cc1ccccc1)C)C |
SMILES | CACTVS | 3.341 | CN[CH](C)Cc1ccccc1 |
SMILES | OpenEye OEToolkits | 1.5.0 | CC(Cc1ccccc1)NC |
Canonical SMILES | CACTVS | 3.341 | CN[C@@H](C)Cc1ccccc1 |
Canonical SMILES | OpenEye OEToolkits | 1.5.0 | C[C@@H](Cc1ccccc1)NC |
InChI | InChI | 1.03 | InChI=1S/C10H15N/c1-9(11-2)8-10-6-4-3-5-7-10/h3-7,9,11H,8H2,1-2H3/t9-/m0/s1 |
InChIKey | InChI | 1.03 | MYWUZJCMWCOHBA-VIFPVBQESA-N |
Drug Info: DrugBank
DrugBank ID | DB01577 |
---|---|
Name | Metamfetamine |
Groups |
|
Description | Metamfetamine (methamphetamine) is a psychostimulant and sympathomimetic drug, and a member of the amphetamine group of sympathomimetic amines. Methamphetamine can induce effects such as euphoria, increased alertness and energy, and enhanced self-esteem. It is a scheduled drug in most countries due to its high potential for addiction and abuse. The FDA withdrew its approval for the use of all parenteral drug products containing methamphetamine hydrochloride, a metamfetamine salt.[L43942] |
Synonyms |
|
Brand Names |
|
Indication | For the treatment of Attention Deficit Disorder with Hyperactivity (ADHD) and exogenous obesity. |
Categories |
|
ATC-Code | N06BA03 |
CAS number | 537-46-2 |
Drug Targets
Name | Target Sequence | Pharmacological Action | Actions |
---|---|---|---|
Sodium-dependent dopamine transporter | MSKSKCSVGLMSSVVAPAKEPNAVGPKEVELILVKEQNGVQLTSSTLTNP... | unknown | negative modulator |
Sodium-dependent serotonin transporter | METTPLNSQKQLSACEDGEDCQENGVLQKVVPTPGDKVESGQISNGYSAV... | unknown | negative modulator |
Sodium-dependent noradrenaline transporter | MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRD... | unknown | negative modulator |
Synaptic vesicular amine transporter | MALSELALVRWLQESRRSRKLILFIVFLALLLDNMLLTVVVPIIPSYLYS... | unknown | inhibitor |
Chromaffin granule amine transporter | MLRTILDAPQRLLKEGRASRQLVLVVVFVALLLDNMLFTVVVPIVPTFLY... | unknown | inhibitor |
View More |
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison
T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS.
Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682
Related Resource References
Resource Name | Reference |
---|---|
Pharos | CHEMBL1201201 |
PubChem | 10836 |
ChEMBL | CHEMBL1201201 |
ChEBI | CHEBI:6809 |
CCDC/CSD | MEXVUI, FAKHOO, CIVFOC10, MIYCUT, OKIPAZ, OKIPED, BAVDIL, BAVDOR, BAVFAF, OSEHEC |
COD | 2218183 |